JP2013537426A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013537426A5 JP2013537426A5 JP2013524945A JP2013524945A JP2013537426A5 JP 2013537426 A5 JP2013537426 A5 JP 2013537426A5 JP 2013524945 A JP2013524945 A JP 2013524945A JP 2013524945 A JP2013524945 A JP 2013524945A JP 2013537426 A5 JP2013537426 A5 JP 2013537426A5
- Authority
- JP
- Japan
- Prior art keywords
- adenovirus
- cancer
- item
- orf3
- impaired
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37421510P | 2010-08-16 | 2010-08-16 | |
| US61/374,215 | 2010-08-16 | ||
| PCT/US2011/048005 WO2012024350A2 (en) | 2010-08-16 | 2011-08-16 | Anti-cancer adenoviruses |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013537426A JP2013537426A (ja) | 2013-10-03 |
| JP2013537426A5 true JP2013537426A5 (https=) | 2014-09-18 |
| JP5905460B2 JP5905460B2 (ja) | 2016-04-20 |
Family
ID=45605646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013524945A Active JP5905460B2 (ja) | 2010-08-16 | 2011-08-16 | 抗がんアデノウイルス |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9187733B2 (https=) |
| EP (1) | EP2606137B1 (https=) |
| JP (1) | JP5905460B2 (https=) |
| KR (1) | KR101667094B1 (https=) |
| CN (1) | CN103180448B (https=) |
| AU (1) | AU2011292119B2 (https=) |
| BR (1) | BR112013003579A2 (https=) |
| CA (1) | CA2807778C (https=) |
| SG (1) | SG187785A1 (https=) |
| WO (1) | WO2012024350A2 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112013003579A2 (pt) * | 2010-08-16 | 2016-06-07 | Salk Inst For Biological Studi | adenovírus, células, e, métodos para tratar câncer |
| CN104411826A (zh) * | 2012-03-13 | 2015-03-11 | 萨克生物研究学院 | 使用腺病毒和化学二聚体的选择性细胞寻靶 |
| SG11201507393TA (en) | 2013-03-14 | 2015-10-29 | Salk Inst For Biological Studi | Oncolytic adenovirus compositions |
| KR102608590B1 (ko) | 2014-09-24 | 2023-12-01 | 솔크 인스티튜트 포 바이올로지칼 스터디즈 | 종양 살상 바이러스 및 이의 사용방법 |
| EP3359175B1 (en) | 2015-10-05 | 2020-09-16 | Salk Institute for Biological Studies | Synthetic adenoviruses with tropism to damaged tissue for use in promoting wound repair and tissue regeneration |
| WO2017147269A1 (en) | 2016-02-23 | 2017-08-31 | Salk Institute For Biological Studies | Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics |
| WO2017147265A1 (en) | 2016-02-23 | 2017-08-31 | Salk Institute For Biological Studies | High throughput assay for measuring adenovirus replication kinetics |
| EP3532082A4 (en) | 2016-12-12 | 2020-08-26 | Salk Institute for Biological Studies | SYNTHETIC ADENOVIRUS TUMOR TARGETING AND THEIR USES |
| EP3634449A4 (en) | 2017-05-08 | 2021-03-17 | Gritstone Oncology, Inc. | ALPHAVIRUS NEOANTIGEN VECTORS |
| CN112292449A (zh) | 2018-04-09 | 2021-01-29 | 萨克生物研究学院 | 具有增强的复制特性的溶瘤腺病毒组合物 |
| MX2021014525A (es) * | 2019-05-30 | 2022-03-17 | Gritstone Bio Inc | Adenovirus modificados. |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA137094A (en) | 1911-08-31 | 1911-11-28 | Sheppe, Alice L. | Cloth measuring and price calculating machine |
| FR2726285B1 (fr) * | 1994-10-28 | 1996-11-29 | Centre Nat Rech Scient | Adenovirus depourvus de particules contaminantes viables, preparation et utilisation |
| ES2180258T3 (es) * | 1998-07-07 | 2003-02-01 | Transgene Sa | Utilizacion de pautas de lectura abierta adenovirales de e4 para mejorar la expresion de genes. |
| EP1083229A1 (en) * | 1999-09-10 | 2001-03-14 | Introgene B.V. | Modified adenoviral vectors for use in gene therapy |
| US7445929B2 (en) * | 2000-05-26 | 2008-11-04 | Dainippon Sumitomo Pharma Co., Ltd. | Recombinant adenovirus vector having a reduced side effect |
| US20020106382A1 (en) * | 2000-07-14 | 2002-08-08 | Young Charles S.H. | Modified adenovirus and uses thereof |
| US20030220284A1 (en) | 2002-02-22 | 2003-11-27 | Patricia Yotnda | Delivery of adenoviral DNA in a liposomal formulation for treatment of disease |
| AU2003223089A1 (en) | 2002-04-29 | 2003-11-17 | Hadasit Medical Research Services And Development Company Ltd. | Compositions and methods for treating cancer with an oncolytic viral agent |
| WO2004031357A2 (en) | 2002-10-01 | 2004-04-15 | Duke University | Targeted tumor therapy by use of recombinant adenovirus vectors that selectively replicate in hypoxic regions of tumors |
| WO2005048950A2 (en) | 2003-11-17 | 2005-06-02 | Biomune, Inc. | Tumor and infectious disease therapeutic compositions |
| KR20110081222A (ko) * | 2008-09-26 | 2011-07-13 | 어번 유니버시티 | 비복제성 벡터화된 백신의 점막 투여에 의한 조류의 면역화 |
| BR112013003579A2 (pt) * | 2010-08-16 | 2016-06-07 | Salk Inst For Biological Studi | adenovírus, células, e, métodos para tratar câncer |
-
2011
- 2011-08-16 BR BR112013003579A patent/BR112013003579A2/pt not_active Application Discontinuation
- 2011-08-16 KR KR1020137006526A patent/KR101667094B1/ko active Active
- 2011-08-16 CA CA2807778A patent/CA2807778C/en active Active
- 2011-08-16 WO PCT/US2011/048005 patent/WO2012024350A2/en not_active Ceased
- 2011-08-16 EP EP11818698.0A patent/EP2606137B1/en active Active
- 2011-08-16 AU AU2011292119A patent/AU2011292119B2/en active Active
- 2011-08-16 JP JP2013524945A patent/JP5905460B2/ja active Active
- 2011-08-16 SG SG2013009790A patent/SG187785A1/en unknown
- 2011-08-16 CN CN201180050032.7A patent/CN103180448B/zh active Active
-
2013
- 2013-02-15 US US13/768,933 patent/US9187733B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013537426A5 (https=) | ||
| Barkauskas et al. | Cellular mechanisms of tissue fibrosis. 7. New insights into the cellular mechanisms of pulmonary fibrosis | |
| AR090470A1 (es) | Vacuna contra el virus sincicial respiratorio (rsv) | |
| MY183703A (en) | Oncolytic adenovirus encoding a b7 protein | |
| MX2024005757A (es) | Virus pichinde de tres segmentos como vectores de vacunas. | |
| RU2016123086A (ru) | Способы и композиции для лечения болезни хантингтона | |
| BR112016020688A2 (pt) | Composições úteis no tratamento da deficiência da ornitina transcarbamilase (otc) | |
| EA201490004A1 (ru) | Применение bifidobacterium lactis bl-04 для лечения заболеваний дыхательных путей | |
| FR2981643B1 (fr) | Procede de preparation d'un materiau composite silicium/carbone, materiau ainsi prepare, et electrode notamment electrode negative, comprenant ce materiau. | |
| JP2013509429A5 (https=) | ||
| WO2015061294A3 (en) | Use of sting agonists to treat chronic hepatitis b virus infection | |
| BR112014015016A8 (pt) | Proteína homodimérica de duas cadeias de aminoácidos idênticas, cadeia de aminoácido, molécula de ácido nucléico, composição farmacêutica, célula hospedeira, método de preparação de uma proteína homodimérica, método para preparação de uma vacina, vacina e método de tratamento ou prevenção | |
| BR112015025464A2 (pt) | coagonistas do receptor de glp-1/glucagon estáveis, prolongados para uso médico | |
| MX360045B (es) | Combinaciones farmacéuticas de un inhibidor de cdk4/6 y un inhibidor de b-raf. | |
| PH12014500865A1 (en) | Compounds and methods for enhancing innate immune responses | |
| JP2011157399A5 (https=) | ||
| BR112014028315A2 (pt) | mposto, métodos para introdução de uma molécula dentro do citosol de uma célula, para obter a morte de uma célula, para expressar uma molécula antigênica ou uma parte da mesma na superfície de uma célula, e para tratamento ou prevenção de uma doença, distúrbio ou infecção em um paciente, composição farmacêutica, célula ou uma população de células, e, kit | |
| JP2017532343A5 (https=) | ||
| MA39096B1 (fr) | Anticorps spécifiques à fcrn | |
| IT1405793B1 (it) | Molecola di u1snrna umano modificato, gene codificante per la molecola di u1snrna umano modificato, vettore di espressione includente il gene, e loro uso in terapia genica | |
| MD4481B1 (ro) | Herpesvirus recombinant Koi (KHV) şi vaccin pentru profilaxia bolii cauzate de KHV | |
| JP2018512597A5 (https=) | ||
| JP2013544892A5 (https=) | ||
| Hu et al. | Oncolytic viruses for the treatment of bladder cancer: advances, challenges, and prospects | |
| JP2014515258A5 (https=) |